RS11126412 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (10)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Metabolite levels (N-acetylphenylalanine; N-acetyphenylalanine) | T | OR: 0.53 | 1E-234 | PubMed |
| Urine N-acetyl-L-2-aminoadipic acid levels in chronic kidney disease | T | OR: 0.29 | 2E-135 | PubMed |
| Metabolite levels (N-acetylkynurenine (2)) | T | OR: 0.55 | 1E-120 | PubMed |
| Creatinine levels in bottom 99% of individuals by creatinine levels | — | OR: 0.57 | 1E-85 | PubMed |
| Estimated glomerular filtration rate based on creatinine and cystatin C in bottom 99% of individuals by creatinine levels | — | OR: 5.23 | 2E-71 | PubMed |
| Urine N-alpha-acetylornithine levels in chronic kidney disease | T | OR: 0.28 | 2E-63 | PubMed |
| Urine N6-carboxyethyllysine levels in chronic kidney disease | T | OR: 0.18 | 2E-38 | PubMed |
| Urine pyrraline levels in chronic kidney disease | T | OR: 0.27 | 3E-27 | PubMed |
| Cystatin C levels in bottom 99% of individuals by creatinine levels | — | β: 0.004 | 6E-26 | PubMed |
| Serum metabolite concentrations in chronic kidney disease | — | OR: 0.36 | 2E-11 | PubMed |